Literature DB >> 22819141

Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization.

Kasper Aanaes1, Helle Krogh Johansen, Steen Seier Poulsen, Tacjana Pressler, Christian Buchwald, Niels Høiby.   

Abstract

BACKGROUND: Pseudomonas aeruginosa sinusitis may be the focus for intermittent lung colonization in patients with cystic fibrosis (CF). The sinusitis may induce elevated IgA levels in nasal secretion and saliva against P. aeruginosa.
METHODS: 120 CF patients chronically infected, intermittently colonized or without P. aeruginosa in the lungs participated in this cross-sectional study. IgA and IgG against P. aeruginosa sonicate and alginate were measured in nasal secretions, saliva, and in serum by ELISA.
RESULTS: The intermittently colonized patients had significantly higher IgA levels in nasal secretions and saliva than those without P. aeruginosa in the lungs, indicating that P. aeruginosa sinusitis may precede intermittent colonization and chronic infection of the lungs.
CONCLUSIONS: Specific IgA against P. aeruginosa in nasal secretions and saliva can contribute to differentiation between patients chronically infected, intermittently colonized, and without P. aeruginosa in the lungs. The diagnostic value of the IgA ELISA awaits a prospective study.
Copyright © 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819141     DOI: 10.1016/j.jcf.2012.07.001

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  23 in total

Review 1.  Management of the upper airway in cystic fibrosis.

Authors:  Elisa A Illing; Bradford A Woodworth
Journal:  Curr Opin Pulm Med       Date:  2014-11       Impact factor: 3.155

Review 2.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

3.  Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.

Authors:  Renan Marrichi Mauch; Claudio Lucio Rossi; Marcos Tadeu Nolasco da Silva; Talita Bianchi Aiello; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Niels Høiby; Carlos Emilio Levy
Journal:  Med Microbiol Immunol       Date:  2019-01-31       Impact factor: 3.402

Review 4.  Tolerance and resistance of microbial biofilms.

Authors:  Oana Ciofu; Claus Moser; Peter Østrup Jensen; Niels Høiby
Journal:  Nat Rev Microbiol       Date:  2022-02-03       Impact factor: 78.297

5.  Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Authors:  Jochen G Mainz; Andrea Gerber; Michael Lorenz; Ruth Michl; Julia Hentschel; Anika Nader; James F Beck; Mathias W Pletz; Andreas H Mueller
Journal:  Case Rep Infect Dis       Date:  2015-03-18

Review 6.  B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Authors:  Martin Rao; Davide Valentini; Thomas Poiret; Ernest Dodoo; Shreemanta Parida; Alimuddin Zumla; Susanna Brighenti; Markus Maeurer
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

7.  Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.

Authors:  Ulrike Müller; Julia Hentschel; Wibke K Janhsen; Kerstin Hünniger; Uta-Christina Hipler; Jürgen Sonnemann; Wolfgang Pfister; Klas Böer; Thomas Lehmann; Jochen G Mainz
Journal:  Mediators Inflamm       Date:  2015-06-21       Impact factor: 4.711

Review 8.  Host responses to mucosal biofilms in the lung and gut.

Authors:  Jada C Domingue; Julia L Drewes; Christian A Merlo; Franck Housseau; Cynthia L Sears
Journal:  Mucosal Immunol       Date:  2020-02-28       Impact factor: 7.313

9.  Sinonasal inhalation of tobramycin vibrating aerosol in cystic fibrosis patients with upper airway Pseudomonas aeruginosa colonization: results of a randomized, double-blind, placebo-controlled pilot study.

Authors:  Jochen G Mainz; Katja Schädlich; Claudia Schien; Ruth Michl; Petra Schelhorn-Neise; Assen Koitschev; Christiane Koitschev; Peter M Keller; Joachim Riethmüller; Baerbel Wiedemann; James F Beck
Journal:  Drug Des Devel Ther       Date:  2014-02-10       Impact factor: 4.162

10.  Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers.

Authors:  Ruth K Michl; Julia Hentschel; Christiane Fischer; James F Beck; Jochen G Mainz
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.